Xue Y - Search Results

1

Association of RNF213 Variants With Periventricular Anastomosis in Moyamoya Disease.

Xue Y, Zeng C, Ge P, Liu C, Li J, Zhang Y, Zhang D, Zhang Q, Zhao J. Xue Y, et al. Stroke. 2022 Sep;53(9):2906-2916. doi: 10.1161/STROKEAHA.121.038066. Epub 2022 May 11. Stroke. 2022. PMID: 35543128

2

Response to Letter to the Editor on "Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810 K Variant".

Zhang Q, Zhao J, Xue Y. Zhang Q, et al. Among authors: xue y. J Child Neurol. 2020 Aug;35(9):623-624. doi: 10.1177/0883073820919314. Epub 2020 May 3. J Child Neurol. 2020. PMID: 32362215 No abstract available.

3

Application of Induced Pluripotent Stem Cells in Moyamoya Disease: Progress and Promises.

Xue Y, Zhang Q, Wang LJ, Tu WJ, Zhao J. Xue Y, et al. Curr Stem Cell Res Ther. 2023;18(6):733-739. doi: 10.2174/1574888X17666220607121027. Curr Stem Cell Res Ther. 2023. PMID: 35674309 Review.

4

N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway.

Wang LJ, Xue Y, Huo R, Yan Z, Xu H, Li H, Wang J, Zhang Q, Cao Y, Zhao JZ. Wang LJ, et al. Among authors: xue y. J Biomed Sci. 2020 May 9;27(1):62. doi: 10.1186/s12929-020-00655-w. J Biomed Sci. 2020. PMID: 32384926 Free PMC article.

5

Tumor Necrosis Factor-α: The Next Marker of Stroke.

Xue Y, Zeng X, Tu WJ, Zhao J. Xue Y, et al. Dis Markers. 2022 Feb 27;2022:2395269. doi: 10.1155/2022/2395269. eCollection 2022. Dis Markers. 2022. PMID: 35265224 Free PMC article. Review.

6

Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke.

Xue Y, Nie D, Wang LJ, Qiu HC, Ma L, Dong MX, Tu WJ, Zhao J. Xue Y, et al. Aging Dis. 2021 Apr 1;12(2):466-479. doi: 10.14336/AD.2020.0701. eCollection 2021 Apr. Aging Dis. 2021. PMID: 33815877 Free PMC article. Review.

7

Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.

Wang LJ, Xue Y, Li H, Huo R, Yan Z, Wang J, Xu H, Wang J, Cao Y, Zhao JZ. Wang LJ, et al. Among authors: xue y. J Cell Mol Med. 2020 May;24(9):4981-4991. doi: 10.1111/jcmm.15101. Epub 2020 Apr 13. J Cell Mol Med. 2020. PMID: 32281240 Free PMC article.

8

Tumor-associated macrophages related signature in glioma.

Wang LJ, Xue Y, Lou Y. Wang LJ, et al. Among authors: xue y. Aging (Albany NY). 2022 Mar 24;14(6):2720-2735. doi: 10.18632/aging.203968. Epub 2022 Mar 24. Aging (Albany NY). 2022. PMID: 35332109 Free PMC article.

9

The Prevalence and Treatment of Diabetes in China From 2013 to 2018.

Tu WJ, Xue Y, Nie D. Tu WJ, et al. Among authors: xue y. JAMA. 2022 May 3;327(17):1706. doi: 10.1001/jama.2022.3014. JAMA. 2022. PMID: 35503354 No abstract available.

10

Immune Checkpoints: Therapeutic Targets for Pituitary Tumors.

Nie D, Xue Y, Fang Q, Cheng J, Li B, Wang D, Li C, Gui S, Zhang Y, Zhao P. Nie D, et al. Among authors: xue y. Dis Markers. 2021 Aug 16;2021:5300381. doi: 10.1155/2021/5300381. eCollection 2021. Dis Markers. 2021. PMID: 34447484 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,395 results

Search Page